+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Desmopressin"

From
Desmopressin - Global Strategic Business Report - Product Thumbnail Image

Desmopressin - Global Strategic Business Report

  • Report
  • May 2024
  • 93 Pages
  • Global
From
Nocturia Drugs - Global Strategic Business Report - Product Thumbnail Image

Nocturia Drugs - Global Strategic Business Report

  • Report
  • May 2024
  • 192 Pages
  • Global
From
Nocturia - Pipeline Insight, 2024 - Product Thumbnail Image

Nocturia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Nocturia - Pipeline Review, H2 2020 - Product Thumbnail Image

Nocturia - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 45 Pages
  • Global
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Desmopressin is a synthetic analogue of the natural hormone arginine vasopressin, used to treat endocrine and metabolic disorders. It is used to treat diabetes insipidus, a condition in which the body does not produce enough antidiuretic hormone, resulting in excessive urination and dehydration. It is also used to treat nocturnal enuresis, or bedwetting, in children. Desmopressin is available in tablet, intranasal spray, and injection forms. Desmopressin is also used to treat von Willebrand disease, a bleeding disorder caused by a deficiency of von Willebrand factor. It is used to increase the level of von Willebrand factor in the blood, allowing it to clot more effectively. Desmopressin is a widely used drug in the endocrine and metabolic disorders market. It is available from many pharmaceutical companies, including Novartis, Pfizer, and Merck. It is also available in generic forms from many generic drug manufacturers. Show Less Read more